US2020037875A1PendingUtilityA1
Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise
Est. expiryMay 18, 2027(~0.8 yrs left)· nominal 20-yr term from priority
Inventors:Peter C. SimpsonRobert J. BoockMark C. BristerMonica A. RixmanKum Ming WooLisa NguyenSeth R. BrunnerArthur CheeMelissa A. NicholasMatthew D. WightlinJack PryorDubravka Markovic
A61B 5/14865A61B 5/14546A61B 5/14735A61B 5/14532A61B 5/6848A61B 5/7203A61B 5/1473A61B 5/00A61B 5/1486
64
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Systems and methods of use involving sensors having a signal-to-noise ratio that is substantially unaffected by non-constant noise are provided for continuous analyte measurement in a host. In some embodiments, a continuous analyte measurement system is configured to be wholly, transcutaneously, intravascularly or extracorporeally implanted.
Claims
exact text as granted — not AI-modified1 - 20 . (canceled)
21 . A transcutaneous electrochemical glucose sensor configured for implantation in a host, the transcutaneous electrochemical glucose sensor comprising:
a first portion configured to remain outside a body of the host during sensor use, wherein the first portion is configured to operably connect with sensor electronics; and a second portion configured to be inserted inside the body of the host during sensor use, wherein the second portion comprises:
a planar substrate;
a working electrode disposed over at least a portion of the planar substrate;
a membrane layer disposed over at least a portion of the working electrode; and
a reference electrode disposed at least in part on the second portion of the transcutaneous electrochemical glucose sensor,
22 . The transcutaneous electrochemical glucose sensor of claim 21 , wherein the membrane layer is configured to control a diffusion of glucose therethrough.
23 . The transcutaneous electrochemical glucose sensor of claim 21 , wherein the membrane layer comprises polyurethane.
24 . The transcutaneous electrochemical glucose sensor of claim 21 , wherein the transcutaneous electrochemical glucose sensor has a planar shape.
25 . The transcutaneous electrochemical glucose sensor of claim 21 , wherein the reference electrode comprises silver and silver chloride.
26 . The transcutaneous electrochemical glucose sensor of claim 21 , further comprising a counter electrode disposed at least in part on the second portion of the transcutaneous electrochemical glucose sensor.Join the waitlist — get patent alerts
Track US2020037875A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.